Advanced search
Publication Cover
Future Cardiology Volume 7, 2011 - Issue 2
Submit an article Journal homepage
288
Views
0
CrossRef citations to date
0
Altmetric
Review

Vascular changes, Cardiovascular Disease and Obstructive Sleep Apnea

Kannan Ramar1 Mayo Clinic Center for Sleep Medicine Division of Pulmonary Sleep & Critical Care Medicine Mayo ClinicRochesterMNUSACorrespondence[email protected]
&
Sean M Caples1 Mayo Clinic Center for Sleep Medicine Division of Pulmonary Sleep & Critical Care Medicine Mayo ClinicRochesterMNUSA
Pages 241-249 | Published online: 31 Mar 2011

Bibliography

  • Young T , PaltaM, DempseyJ, SkatrudJ, WeberS, BadrS: The occurrence of sleep-disordered breathing among middle-aged adults.N. Engl. J. Med., 328(17), 1230–1235 (1993).
  • Marin JM , CarrizoSJ, VicenteE, AgustiAG: Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study.Lancet, 365(9464), 1046–1053 (2005).
  • Young T , FinnL, PeppardPEet al.: Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort.Sleep, 31(8), 1071–1078 (2008).
  • Shiomi T , GuilleminaultC, StoohsR, SchnittgerI: Leftward shift of the interventricular septum and pulsus paradoxus in obstructive sleep apnea syndrome.Chest, 100(4), 894–902 (1991).
  • Bradley TD , FlorasJS: Sleep apnea and heart failure: part I: obstructive sleep apnea.Circulation, 107(12), 1671–1678 (2003).
  • Fletcher EC , ProctorM, YuJet al.: Pulmonary edema develops after recurrent obstructive apneas.Am. J. Respir. Crit. Care Med., 160(5 Pt 1), 1688–1696 (1999).
  • Chen L , ShiQ, ScharfSM: Hemodynamic effects of periodic obstructive apneas in sedated pigs with congestive heart failure.J. Appl. Physiol., 88(3), 1051–1060 (2000).
  • Hall MJ , AndoS, FlorasJS, BradleyTD: Magnitude and time course of hemodynamic responses to Mueller maneuvers in patients with congestive heart failure.J. Appl. Physiol., 85(4), 1476–1484 (1998).
  • Naughton MT : Impact of treatment of sleep apnoea on left ventricular function in congestive heart failure.Thorax, 53(Suppl. 3), S37–S40 (1998).
  • Tkacova R , RankinF, FitzgeraldFS, FlorasJS, BradleyTD: Effects of continuous positive airway pressure on obstructive sleep apnea and left ventricular afterload in patients with heart failure.Circulation, 98(21), 2269–2275 (1998).
  • Somers VK , DykenME, ClaryMP, AbboudFM: Sympathetic neural mechanisms in obstructive sleep apnea.J. Clin. Invest., 96(4), 1897–1904 (1995).
  • Guo GB , AbboudFM: Angiotensin II attenuates baroreflex control of heart rate and sympathetic activity.Am. J. Physiol., 246(1 Pt 2), H80–H89 (1984).
  • Fletcher EC , BaoG, LiR: Renin activity and blood pressurein response to chronic episodic hypoxia.Hypertension, 34(2), 309–314 (1999).
  • Moller DS , LindP, StrungeB, PedersenEB: Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea.Am. J. Hypertens., 16(4), 274–280 (2003).
  • Bravo EL , Fouad-TaraziFM, TaraziRC, PohlM, GiffordRW, VidtDG: Clinical implications of primary aldosteronism with resistant hypertension.Hypertension, 11(2 Pt 2), I207–1211 (1988).
  • Calhoun DA , NishizakaMK, ZamanMA, HardingSM: Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea.Chest, 125(1), 112–117 (2004).
  • Gjorup PH , SadauskieneL, WesselsJ, NyvadO, StrungeB, PedersenEB: Abnormally increased endothelin-1 in plasma during the night in obstructive sleep apnea: relation to blood pressure and severity of disease.Am. J. Hypertens., 20(1), 44–52 (2007).
  • Pratt-Ubunama MN , NishizakaMK, BoedefeldRL, CofieldSS, HardingSM, CalhounDA: Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension.Chest, 131(2), 453–459 (2007).
  • Gaddam K , PimentaE, ThomasSJet al.: Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report.J. Hum Hypertens., 24(8), 532–537 (2010).
  • Svatikova A , OlsonLJ, WolkRet al.: Obstructive sleep apnea and aldosterone.Sleep, 32(12), 1589–1592 (2009).
  • Kanagy NL , WalkerBR, NelinLD: Role of endothelin in intermittent hypoxia-induced hypertension.Hypertension, 37(2 Part 2), 511–515 (2001).
  • Phillips BG , NarkiewiczK, PesekCA, HaynesWG, DykenME, SomersVK: Effects of obstructive sleep apnea on endothelin-1 and blood pressure.J. Hypertens., 17(1), 61–66 (1999).
  • Saarelainen S , SeppalaE, LaasonenK, HasanJ: Circulating endothelin-1 in obstructive sleep apnea.Endothelium, 5(2), 115–118 (1997).
  • Zamarron-Sanz C , Ricoy-GalbaldonJ, Gude-SampedroF, Riveiro-RiveiroA: Plasma levels of vascular endothelial markers in obstructive sleep apnea.Arch. Med. Res., 37(4), 552–555 (2006).
  • Grimpen F , KanneP, SchulzE, HagenahG, HasenfussG, AndreasS: Endothelin-1 plasma levels are not elevated in patients with obstructive sleep apnoea.Eur. Respir. J., 15(2), 320–325 (2000).
  • Hiltunen TP , SuonsyrjaT, Hannila-HandelbergTet al.: Predictors of antihypertensive drug responses: initial data from a placebo-controlled, randomized, cross-over study with four antihypertensive drugs (The GENRES Study).Am. J. Hypertens., 20(3), 311–318 (2007).
  • Dyugovskaya L , LavieP, LavieL: Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients.Am. J. Respir. Crit. Care Med., 165(7), 934–939 (2002).
  • Harrison R : Structure and function of xanthine oxidoreductase: where are we now?Free Rad. Biol. Med., 33(6), 774–797 (2002).
  • McKelvey TG , HollwarthME, GrangerDN, EngersonTD, LandlerU, JonesHP: Mechanisms of conversion of xanthine dehydrogenase to xanthine oxidase in ischemic rat liver and kidney.Am. J. Physiol., 254(5 Pt 1), G753–G760 (1988).
  • El Solh AA , SalibaR, BosinskiT, GrantBJ, BerbaryE, MillerN: Allopurinol improves endothelial function in sleep apnoea: a randomised controlled study.Eur. Respir. J. 2006 27(5), 997–1002.
  • Glantzounis GK , TsimoyiannisEC, KappasAM, GalarisDA: Uric acid and oxidative stress.Curr. Pharm. Des., 11(32), 4145–4151 (2005).
  • Budhiraja R , KayyaliUS, KaramsettyMet al.: Estrogen modulates xanthine dehydrogenase/xanthine oxidase activity by a receptor-independent mechanism.Antioxid. Redox Signal., 5(6), 705–711 (2003).
  • Braghiroli A , SaccoC, ErbettaM, RugaV, DonnerCF: Overnight urinary uric acid: creatinine ratio for detection of sleep hypoxemia. Validation study in chronic obstructive pulmonary disease and obstructive sleep apnea before and after treatment with nasal continuous positive airway pressure.Am. Rev. Respir. Dis., 148(1), 173–178 (1993).
  • Lavie L , VishnevskyA, LavieP: Evidence for lipid peroxidation in obstructive sleep apnea.Sleep, 27(1), 123–128 (2004).
  • Barcelo A , MirallesC, BarbeF, VilaM, PonsS, AgustiAG: Abnormal lipid peroxidation in patients with sleep apnoea.Eur. Respir. J., 16(4), 644–647(2000).
  • Carpagnano GE , KharitonovSA, RestaO, Foschino-BarbaroMP, GramiccioniE, BarnesPJ: 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy.Chest, 124(4), 1386–1392 (2003).
  • Christou K , MarkoulisN, MoulasAN, PastakaC, GourgoulianisKI: Reactive oxygen metabolites (ROMs) as an index of oxidative stress in obstructive sleep apnea patients.Sleep Breath., 7(3), 105–110 (2003).
  • Christou K , KostikasK, PastakaC, TanouK, AntoniadouI, GourgoulianisKI: Nasal continuous positive airway pressure treatment reduces systemic oxidative stress in patients with severe obstructive sleep apnea syndrome.Sleep Med., 10(1), 87–94 (2009).
  • Yamauchi M , NakanoH, MaekawaJet al.: Oxidative stress in obstructive sleep apnea.Chest, 127(5), 1674–1679 (2005).
  • Cave A , GrieveD, JoharS, ZhangM, ShahAM: NADPH oxidase-derived reactive oxygen species in cardiac pathophysiology.Philos. Trans. R. Soc. Lond. B Biol. Sci., 360(1464), 2327–2334 (2005).
  • Khan SA , LeeK, MinhasKMet al.: Neuronal nitric oxide synthase negatively regulates xanthine oxidoreductase inhibition of cardiac excitation-contraction coupling.Proc. Natl Acad. Sci. USA, 101(45), 15944–15948 (2004).
  • Christou K , MoulasAN, PastakaC, GourgoulianisKI: Antioxidant capacity in obstructive sleep apnea patients.Sleep Med., 4(3), 225–228 (2003).
  • Barcelo A , BarbeFet al., de la Pena M : Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment. Eur. Respir. J., 27(4), 756–760 (2006).
  • Brevetti G , SilvestroA, SchianoV, ChiarielloM: Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index.Circulation, 108(17), 2093–2098 (2003).
  • Koller A , HuangA: Impaired nitric oxide-mediated flow-induced dilation in arterioles of spontaneously hypertensive rats.Circ. Res., 74(3), 416–421 (1994).
  • Kato M , Roberts-ThomsonP, PhillipsBGet al.: Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea.Circulation, 102(21), 2607–2610 (2000).
  • Nieto FJ , HerringtonDM, RedlineS, BenjaminEJ, RobbinsJA: Sleep apnea and markers of vascular endothelial function in a large community sample of older adults.Am. J. Respir. Crit. Care Med., 169(3), 354–360 (2004).
  • Grebe M , EiseleHJ, WeissmannNet al.: Antioxidant vitamin C improves endothelial function in obstructive sleep apnea.Am. J. Respir. Crit. Care Med., 173(8), 897–901 (2006).
  • Chin K , ShimizuK, NakamuraTet al.: Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy.Circulation, 100(7), 706–712 (1999).
  • Harsch IA , KonturekPC, KoebnickCet al.: Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment.Eur. Respir. J., 22(2), 251–257 (2003).
  • Singhal A , FarooqiIS, ColeTJet al.: Influence of leptin on arterial distensibility: a novel link between obesity and cardiovascular disease?Circulation, 106(15), 1919–1924 (2002).
  • Luo JD , ZhangGS, ChenMS: Leptin and cardiovascular diseases.Drug News Pers. (7), 427–431 (2005).
  • Parhami F , TintutY, BallardA, FogelmanAM, DemerLL: Leptin enhances the calcification of vascular cells: artery wall as a target of leptin.Circ. Res., 88(9), 954–960 (2001).
  • Schafer K , HalleM, GoeschenCet al.: Leptin promotes vascular remodeling and neointimal growth in mice.Arterioscler. Thromb. Vasc. Biol., 24(1), 112–117 (2004).
  • Bokinsky G , MillerM, AultK, HusbandP, MitchellJ: Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure. A preliminary investigation.Chest, 108(3), 625–630 (1995).
  • Rangemark C , HednerJA, CarlsonJT, GleerupG, WintherK: Platelet function and fibrinolytic activity in hypertensive and normotensive sleep apnea patients.Sleep, 18(3), 188–194 (1995).
  • von Kanel R , DimsdaleJE: Hemostatic alterations in patients with obstructive sleep apnea and the implications for cardiovascular disease.Chest, 124(5), 1956–1967 (2003).
  • Robinson GV , PepperellJC, SegalHC, DaviesRJ, StradlingJR: Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials.Thorax, 59(9), 777–782 (2004).
  • Rosenberg RD , AirdWC: Vascular-bed- specific hemostasis and hypercoagulable states.N. Engl. J. Med., 340(20), 1555–1564 (1999).
  • Libby P : Inflammation in atherosclerosis.Nature, 420(6917), 868–874 (2002).
  • Puig F , RicoF, AlmendrosI, MontserratJM, NavajasD, FarreR: Vibration enhances interleukin-8 release in a cell model of snoring-induced airway inflammation.Sleep, 28(10), 1312–1316 (2005).
  • Ryan S , TaylorCT, McNicholasWT: Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome.Circulation, 112(17), 2660–2667 (2005).
  • Ryan S , TaylorCT, McNicholasWT: Predictors of elevated nuclear factor-κB-dependent genes in obstructive sleep apnea syndrome.Am. J. Respir. Crit. Care Med., 174(7), 824–830 (2006).
  • Ryan S , TaylorCT, McNicholasWT: Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome?Thorax, 64(7), 631–636 (2009).
  • Vgontzas AN , PapanicolaouDA, BixlerEO, KalesA, TysonK, ChrousosGP: Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity.J. Clin. Endocrinol. Metab., 82(5), 1313–1316 (1997).
  • Htoo AK , GreenbergH, TongiaSet al.: Activation of nuclear factor κB in obstructive sleep apnea: a pathway leading to systemic inflammation.Sleep Breath., 10(1), 43–50 (2006).
  • Ridker PM , RifaiN, RoseL, BuringJE, CookNR: Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.N. Engl. J. Med., 347(20), 1557–1565 (2002).
  • Fichtlscherer S , RosenbergerG, WalterDH, BreuerS, DimmelerS, ZeiherAM: Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease.Circulation, 102(9), 1000–1006 (2000).
  • Pepys MB , HirschfieldGM: C-reactive protein: a critical update.J. Clin. Invest., 111(12), 1805–1812 (2003).
  • Shamsuzzaman AS , WinnickiM, LanfranchiPet al.: Elevated C-reactive protein in patients with obstructive sleep apnea.Circulation, 105(21), 2462–2464 (2002).
  • Guilleminault C , KirisogluC, OhayonMM: C-reactive protein and sleep-disordered breathing.Sleep, 27(8), 1507–1511 (2004).
  • Larkin EK , RosenCL, KirchnerHLet al.: Variation of C-reactive protein levels in adolescents: association with sleep-disordered breathing and sleep duration.Circulation, 111(15), 1978–1984 (2005).
  • Yokoe T , MinoguchiK, MatsuoHet al.: Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure.Circulation, 107(8), 1129–1134 (2003).
  • Luc G , BardJM, Juhan-VagueIet al.: C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study.Arterioscler. Thromb. Vasc. Biol., 23(7), 1255–1261 (2003).
  • Romano M , SironiM, ToniattiCet al.: Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment.Immunity, 6(3), 315–325 (1997).
  • Mehra R , Storfer-IsserA, KirchnerHLet al.: Soluble interleukin 6 receptor: a novel marker of moderate to severe sleep-related breathing disorder.Arch. Intern. Med., 166(16), 1725–1731 (2006).
  • El-Solh AA , MadorMJ, SikkaP, DhillonRS, AmsterdamD, GrantBJ: Adhesion molecules in patients with coronary artery disease and moderate-to-severe obstructive sleep apnea.Chest, 121(5), 1541–1547 (2002).
  • Ohga E , NagaseT, TomitaTet al.: Increased levels of circulating ICAM-1, VCAM-1 and L-selectin in obstructive sleep apnea syndrome.J. Appl. Physiol., 87(1), 10–14 (1999).
  • Price DT , LoscalzoJ: Cellular adhesion molecules and atherogenesis.Am. J. Med., 107(1), 85–97 (1999).
  • Lavie L , LavieP: Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link.Eur. Respir. J., 33(6), 1467–1484 (2009).
  • Dyugovskaya L , PolyakovA, LavieP, LavieL: Delayed neutrophil apoptosis in patients with sleep apnea.Am. J. Respir. Crit. Care Med., 177(5), 544–554 (2008).
  • Minoguchi K , YokoeT, TazakiTet al.: Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea.Am. J. Respir. Crit. Care Med., 172(5), 625–630 (2005).
  • Drager LF , BortolottoLA, LorenziMC, FigueiredoAC, KriegerEM, Lorenzi-FilhoG: Early signs of atherosclerosis in obstructive sleep apnea.Am. J. Respir. Crit. Care Med., 172(5), 613–618 (2005).
  • Drager LF , BortolottoLA, FigueiredoAC, KriegerEM, LorenziGF: Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea.Am. J. Respir. Crit. Care Med., 176(7), 706–712 (2007).
  • Laurent S , CockcroftJet al., Van Bortel L : Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur. Heart J., 27(21), 2588–2605 (2006).
  • Vlachopoulos C , AznaouridisK, StefanadisC: Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis.J. Am. Coll. Cardiol., 55(13), 1318–1327.
  • Drager LF , BortolottoLA, FigueiredoAC, SilvaBC, KriegerEM, Lorenzi-FilhoG: Obstructive sleep apnea, hypertension, and their interaction on arterial stiffness and heart remodeling.Chest, 131(5), 1379–1386 (2007).
  • Drager LF , BortolottoLA, Maki-NunesCet al.: Atherosclerosis in obstructive sleep apnoea: it does not matter whether patients are sleepy or not.Atherosclerosis, 211(1), 30–31.
  • Tsioufis C , ThomopoulosK, DimitriadisKet al.: The incremental effect of obstructive sleep apnoea syndrome on arterial stiffness in newly diagnosed essential hypertensive subjects.J. Hypertens., 25(1), 141–146 (2007).
  • Kohler M , PepperellJC, CasadeiBet al.: CPAP and measures of cardiovascular risk in males with OSAS.Eur. Respir. J., 32(6), 1488–1496 (2008).
  • Lorenzi-Filho G , DragerLF: Obstructive sleep apnea and atherosclerosis: a new paradigm.Am. J. Respir. Crit. Care Med., 175(12), 1219–1221 (2007).
  • Saito T , SaitoT, SugiyamaS, AsaiK, YasutakeM, MizunoK: Effects of long-term treatment for obstructive sleep apnea on pulse wave velocity.Hypertens. Res., 33(8), 844–849 (2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.